Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Theraputic Use
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 61/368,513, filed Jul 28, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,938,501 | Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Theraputic Use In force · High confidence UsedRemaining | Jointechlabs, Inc. | In force | High confidence | ||
| US 11,447,748 | Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Theraputic Use In force · High confidence | JoinTechLabs, Inc. | In force | High confidence | ||
| US 10,745,666 | Encapsulated Adipose-Derived Stem Cells, Methods for Preparation and Therapeutic Use In force · High confidence | JointechLabs, Inc. | In force | High confidence | ||
| Application 13/245,639 | Orthopedic Application of Encapsulated Stem Cells Abandoned Abandoned Oct 16, 2014 | Jointechlabs, Inc. | Abandoned | Abandoned Oct 16, 2014 |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Jointechlabs, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.